Stock Events

Stock Events

Alpha Tau Medical 

€11.39
133
-€0.57-4.77%Friday 07:16

Statistics

Day High
11.39
Day Low
11.39
52W High
13.68
52W Low
10.45
Volume
-
Avg. Volume
-
Mkt Cap
1.05B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 24Expected
Q2 2026
Next
-0.43
-0.33
-0.23
-0.12
Expected EPS
-0.1316638358
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-36.91MNet Income

Analyst Ratings

$12.90Average Price Target
The highest estimate is ⁦22.76⁩.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow H44.MU. It's not an investment recommendation.
AST SpaceMobile
28
ASTS
NVIDIA
27
NVDA
Rocket Lab
25
RKLB
Micron Technology
24
MU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.55B
Accuray Incorporated designs and manufactures radiation oncology systems, offering similar cancer treatment solutions.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical provides robotic surgical systems, which are used in minimally invasive surgeries, including cancer-related procedures.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. focuses on orthopedic and medical devices but competes in the broader medical technology market for cancer treatments.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc offers various healthcare solutions, including technologies and therapies for treating cancer, overlapping with Alpha Tau's market.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation manufactures medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation develops medical devices used in interventional medical specialties, competing in the oncology space.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a range of hospital and renal products, including technologies applicable in cancer treatment settings.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers medical devices, diagnostics, and nutritional products that serve various healthcare needs including oncology.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of healthcare products, indirectly competing in the oncology sector.

About

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Show More
CEO
Uzi Sofer
Employees
121
Country
Israel
ISIN
IL0011839383
WKN
000A3DG50

Listings

XNAS
US
DRTS
TA
IL
DRTS.TA
XNAS
US
DRTSW
F
DE
H44.F

0 Comments

Share your thoughts

FAQs

What is Alpha Tau Medical stock price today?▼
The current price of H44.MU is €11.39 EUR — it has decreased by -4.77% in the past 24 hours. Watch Alpha Tau Medical stock price performance more closely on the chart.
What is Alpha Tau Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Alpha Tau Medical stocks are traded under the ticker H44.MU.
What is Alpha Tau Medical market cap?▼
Today Alpha Tau Medical has the market capitalization of 1.05B
When is the next Alpha Tau Medical earnings date?▼
Alpha Tau Medical is going to release the next earnings report on November 24, 2026.
What were Alpha Tau Medical earnings last quarter?▼
H44.MU earnings for the last quarter are -0.43 EUR per share, whereas the estimation was -0.12 EUR resulting in a -254.92% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Alpha Tau Medical revenue for the last year?▼
Alpha Tau Medical revenue for the last year amounts to 0 EUR.
What is Alpha Tau Medical net income for the last year?▼
H44.MU net income for the last year is -36.91M EUR.
How many employees does Alpha Tau Medical have?▼
As of November 8, 2026, the company has 121 employees.
In which sector is Alpha Tau Medical located?▼
Alpha Tau Medical operates in the Health & Wellness sector.
When did Alpha Tau Medical complete a stock split?▼
Alpha Tau Medical has not had any recent stock splits.
Where is Alpha Tau Medical headquartered?▼
Alpha Tau Medical is headquartered in Jerusalem, Israel.